Alfresa Holdings Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ARHCF research report →
About the company
Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, Manufacturing, and Medical-related.
- CEO
- Ryuji Arakawa
- IPO
- 2007
- Employees
- 12,452
- HQ
- Tokyo, SA, JP
Price Chart
- Market Cap
- $2.16B
- P/E
- 9.48
- P/S
- 0.13
- P/B
- 0.78
- EV/EBITDA
- 3.08
- Div Yield
- 3.12%
- Gross Margin
- 7.02%
- Op Margin
- 1.17%
- Net Margin
- 1.34%
- ROE
- 8.48%
- ROIC
- 4.28%
- Revenue
- $3.12T · 5.49%
- Net Income
- $42.01B · 53.38%
- EPS
- $231.68 · 57.03%
- Op Income
- $36.25B
- FCF YoY
- 211.88%
- 52W High
- $11.87
- 52W Low
- $11.87
- 50D MA
- $11.87
- 200D MA
- $11.87
- Beta
- 0.08
- Avg Volume
- 412
Get TickerSpark's AI analysis on ARHCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our ARHCF coverage
Recent articles, reports, and earnings notes.
No research on ARHCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ARHCF report →Similar companies
Peers in the same neighborhood.